ARCHIMED has acquired a majority stake in Cardioline, a leading Italian provider of cardiology-focused telemedicine, to leverage its innovative product offerings and expand into new markets.

Target Information

ARCHIMED, a private equity healthcare specialist, has acquired a majority stake in Cardioline, a leading provider of cardiology-focused telemedicine based in Trento, Italy. Established in 1962, Cardioline has gained a reputation as one of Europe’s most reliable brands in manufacturing traditional cardiology devices and services. Currently, the company meets 20% of the hospital demand and 50% of physician demand for electrocardiogram machines in Italy. Moreover, Cardioline is the largest provider of telemedicine services focused on cardiology in Europe, utilizing proprietary online technology and software for remote testing and diagnostics.

The company has demonstrated a strong commitment to innovation, having released nine new products over the past five years, accompanied by a robust pipeline for future advancements. Cardioline’s core competencies lie in integrating mobile electrocardiography and stress-testing devices with cutting-edge software solutions, enabling significant growth potential both organically and through strategic acquisitions.

Industry Overview in Italy

In Italy, the healthcare sector, particularly telemedicine, has witnessed a rapid transformation over the past few years. The increasing demand for remote healthcare solutions, catalyzed by the COVID-19 pandemic, has led to an expan